title: Clinicopathological characteristics and prognosis of remnant gastric cancer.
abstract: OBJECTIVE
  The long-term survival rate of gastric cancer patients after surgery has recently increased as a result of making an early diagnosis of gastric cancer. Therefore, the incidence of remnant gastric cancer is increasing. This study was performed to evaluate the clinicopathological characteristics and prognosis of patients with remnant gastric cancer.
  
  
  METHODS
  From January 2005 to December 2009, twenty-nine patients with remnant gastric cancer and who underwent surgery at Pusan National University Hospital were enrolled in this study. We retrospectively reviewed and analyzed their medical records. We also divided them into two groups: the remnant gastric cancer (RGC)-B group (first operation for benign disease) and the RGC-M group (first operation for malignant disease).
  
  
  RESULTS
  The RGC-B group included ten patients and the RGC-M group included nineteen patients. The mean interval between the first and second operations was 17 years. The curative resection rate was 93.1% (27/29). The postoperative complication rate was 20.7% (6/29) and there was no perioperative mortality. Ten (37%) of twenty-seven patients experienced recurrence after curative resection and eight patients (27.6%) expired due to aggravation of remnant stomach cancer. An advanced TNM stage and non-curative resection were the negative prognostic factors for survival for patients with remnant stomach cancer (P=0.0453 and P<0.001). The RGC-M group showed a shorter interval (P<0.001) and the RGC-B group had more advanced TNM stage (P=0.003).
  
  
  CONCLUSIONS
  Long-term follow-up should be considered not only for patients who undergo an operation for malignant disease, but also for the patients who underwent an operation for benign disease. When remnant gastric cancer is diagnosed, curative resection is essential to improve the survival.
authors.affiliation: Department of Surgery, Postgraduate School of Medicine, Pusan National University, Busan, Korea.
authors.forename: Sang Bong
authors.initials: SB
authors.lastname: Lee
authors.forename: Jae Hun
authors.initials: JH
authors.lastname: Kim
authors.forename: Dae Hwan
authors.initials: DH
authors.lastname: Kim
authors.forename: Tae Yong
authors.initials: TY
authors.lastname: Jeon
authors.forename: Dong Heon
authors.initials: DH
authors.lastname: Kim
authors.forename: Gwang Ha
authors.initials: GH
authors.lastname: Kim
authors.forename: Do Youn
authors.initials: DY
authors.lastname: Park
references.citation: Ann Surg. 2000 Feb;231(2):188-94
references.pmid: 10674609
references.citation: Ann Surg Oncol. 2008 Jun;15(6):1632-9
references.pmid: 18379851
references.citation: Eur J Surg Oncol. 1997 Dec;23(6):518-21
references.pmid: 9484922
references.citation: Br J Surg. 2007 Jan;94(1):92-5
references.pmid: 17054314
references.citation: Br J Surg. 1993 Jan;80(1):54-6
references.pmid: 8428294
references.citation: Gut. 1998 Sep;43(3):342-4
references.pmid: 9863478
references.citation: Eur J Surg Oncol. 2007 Mar;33(2):133-9
references.pmid: 17071041
references.citation: Cancer. 1996 Apr 15;77(8 Suppl):1646-53
references.pmid: 8608557
references.citation: J Nippon Med Sch. 2002 Oct;69(5):489-93
references.pmid: 12382013
references.citation: J Gastrointest Surg. 2008 Apr;12(4):689-94
references.pmid: 18080844
references.citation: Langenbecks Arch Surg. 2009 Jan;394(1):93-7
references.pmid: 18607624
references.citation: J Am Coll Surg. 1996 Jan;182(1):1-6
references.pmid: 8542082
references.citation: J Surg Oncol. 2009 Nov 1;100(6):472-6
references.pmid: 19697396
references.citation: J Gastrointest Surg. 2010 Feb;14(2):277-81
references.pmid: 19911236
references.citation: Gastric Cancer. 2002;5(3):177-82
references.pmid: 12378346